EE200000638A - 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm - Google Patents
1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vormInfo
- Publication number
- EE200000638A EE200000638A EEP200000638A EEP200000638A EE200000638A EE 200000638 A EE200000638 A EE 200000638A EE P200000638 A EEP200000638 A EE P200000638A EE P200000638 A EEP200000638 A EE P200000638A EE 200000638 A EE200000638 A EE 200000638A
- Authority
- EE
- Estonia
- Prior art keywords
- chloronaphth
- ylsulfonyl
- piperazine
- pyridyl
- benzoyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809350.3A GB9809350D0 (en) | 1998-05-02 | 1998-05-02 | Novel salt |
| PCT/GB1999/001316 WO1999057112A1 (en) | 1998-05-02 | 1999-04-27 | Reduced particle size form of 1-(6-chloronaphth-2- ylsulphonyl) -4-[4-(4pyridyl) benzoyl] piperazine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200000638A true EE200000638A (et) | 2002-04-15 |
Family
ID=10831311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000638A EE200000638A (et) | 1998-05-02 | 1999-04-27 | 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP1084118A1 (xx) |
| JP (1) | JP2002513789A (xx) |
| KR (1) | KR20010043216A (xx) |
| CN (1) | CN1308629A (xx) |
| AU (1) | AU3719699A (xx) |
| BR (1) | BR9910176A (xx) |
| CA (1) | CA2331041A1 (xx) |
| EE (1) | EE200000638A (xx) |
| GB (1) | GB9809350D0 (xx) |
| HU (1) | HUP0102394A3 (xx) |
| IL (1) | IL139405A0 (xx) |
| NO (1) | NO20005498D0 (xx) |
| PL (1) | PL343705A1 (xx) |
| SK (1) | SK16522000A3 (xx) |
| WO (1) | WO1999057112A1 (xx) |
| ZA (1) | ZA200006036B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69833036T2 (de) * | 1997-09-30 | 2006-06-22 | Daiichi Pharmaceutical Co., Ltd. | Sulfonylderivate |
| TWI290136B (en) | 2000-04-05 | 2007-11-21 | Daiichi Seiyaku Co | Ethylenediamine derivatives |
| WO2003000657A1 (fr) | 2001-06-20 | 2003-01-03 | Daiichi Pharmaceutical Co., Ltd. | Derives de diamine |
| DK1569912T3 (en) | 2002-12-03 | 2015-06-29 | Pharmacyclics Inc | 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors. |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA56197C2 (uk) * | 1996-11-08 | 2003-05-15 | Зенека Лімітед | Гетероциклічні похідні |
| ATE334975T1 (de) * | 1997-05-30 | 2006-08-15 | Takeda Pharmaceutical | Sulfonamidderivate, ihre herstellung und verwendung |
| DE69833036T2 (de) * | 1997-09-30 | 2006-06-22 | Daiichi Pharmaceutical Co., Ltd. | Sulfonylderivate |
-
1998
- 1998-05-02 GB GBGB9809350.3A patent/GB9809350D0/en not_active Ceased
-
1999
- 1999-04-27 EE EEP200000638A patent/EE200000638A/xx unknown
- 1999-04-27 PL PL99343705A patent/PL343705A1/xx not_active Application Discontinuation
- 1999-04-27 WO PCT/GB1999/001316 patent/WO1999057112A1/en not_active Application Discontinuation
- 1999-04-27 KR KR1020007012149A patent/KR20010043216A/ko not_active Application Discontinuation
- 1999-04-27 BR BR9910176-9A patent/BR9910176A/pt not_active IP Right Cessation
- 1999-04-27 IL IL13940599A patent/IL139405A0/xx unknown
- 1999-04-27 SK SK1652-2000A patent/SK16522000A3/sk unknown
- 1999-04-27 CA CA002331041A patent/CA2331041A1/en not_active Abandoned
- 1999-04-27 EP EP99919395A patent/EP1084118A1/en not_active Withdrawn
- 1999-04-27 CN CN99808217A patent/CN1308629A/zh active Pending
- 1999-04-27 JP JP2000547082A patent/JP2002513789A/ja active Pending
- 1999-04-27 HU HU0102394A patent/HUP0102394A3/hu unknown
- 1999-04-27 AU AU37196/99A patent/AU3719699A/en not_active Abandoned
-
2000
- 2000-10-25 ZA ZA200006036A patent/ZA200006036B/en unknown
- 2000-11-01 NO NO20005498A patent/NO20005498D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SK16522000A3 (sk) | 2001-05-10 |
| WO1999057112A1 (en) | 1999-11-11 |
| HUP0102394A2 (hu) | 2001-12-28 |
| HUP0102394A3 (en) | 2003-01-28 |
| ZA200006036B (en) | 2002-01-25 |
| IL139405A0 (en) | 2001-11-25 |
| NO20005498L (no) | 2000-11-01 |
| JP2002513789A (ja) | 2002-05-14 |
| BR9910176A (pt) | 2001-01-09 |
| GB9809350D0 (en) | 1998-07-01 |
| NO20005498D0 (no) | 2000-11-01 |
| CN1308629A (zh) | 2001-08-15 |
| CA2331041A1 (en) | 1999-11-11 |
| EP1084118A1 (en) | 2001-03-21 |
| KR20010043216A (ko) | 2001-05-25 |
| AU3719699A (en) | 1999-11-23 |
| PL343705A1 (en) | 2001-08-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60125980D1 (de) | P38kinase-inhibitoren vom piperidin/piperazin-typ | |
| NO20015746D0 (no) | Ny anvendelse av 1-[4-(5-cyanindol-3-yl)butyl]-4-(2- karbamoylbenzofuran-5-yl)-piperazin og dets fysiologisk akseptablesalter | |
| NO20000115L (no) | Gastrokinetiske monocykliske benzamidler av 3- eller 4- substituerte 4-(aminometyl)-piperidinderivater | |
| DE60044004D1 (de) | Verwendung von Omega-Carboxyaryl-substituierten Diphenylharnstoffen als raf-Kinase-Inhibitoren | |
| EE200400019A (et) | 1-[4-(5-tsüanoindool-3-üül)butüül]-4-(2-karbamoüülbensofuraan-5-üül)piperasiinvesin ikkloriidi polümorfsed vormid | |
| LTPA2008002I1 (lt) | Pirolu pakeisti 2-indolinono proteinkinazės inhibitoriai | |
| CY1109347T1 (el) | Συνδυασμος που αποτελειται απο εναν αναστολεα μεταλλαγης σηματος και ενα παραγωγο εποθιλονης | |
| NO20025365D0 (no) | Piperazin- og piperidinforbindelser | |
| NO20032315D0 (no) | 4-(bifenylkarbonylamino)piperidinderivater som MTP- inhibitorer | |
| SG127737A1 (en) | Piperidine and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases | |
| EE200000638A (et) | 1-(6-kloronaft-2-üülsulfonüül)-4-[4-(4-püridüül)bensoüül]-piperasiini vähendatud osakesesuurusega vorm | |
| ATE277053T1 (de) | 2-(4-pyridinyl)-benzofurane zur verwendung als metalloprotease-inhibitoren | |
| ID26146A (id) | Proses untuk cis-1-{2-[4-(6-metoksi-2-fenil-1,2,3,4-tetrahidronaftalen-1-il]fenoksi]etil} pirolidin | |
| DE50304858D1 (de) | N-'4-(2-imino-pyrrolidin-1-yl)phenyl)-acetemid-und entsprechende piperidinderivate als faktor xa inhibitoren zur behandlung von thromboembolischen erkrankungen | |
| DK1353906T3 (da) | Fremgangsmåde til fremstilling af (3-cyano-1H-indol-7-yl)(4-(4-fluorphenetyl)piperazin-1-yl)-methanon og salte deraf | |
| ATE298333T1 (de) | Synthese von 4-(piperidyl) (2-pyridyl)methanon- (e)-o-methyloxim und seinen salzen | |
| AU2000246280A1 (en) | Tosylate salts of 4-(p-fluorophenyl)-piperidine-3-carbinols | |
| NO20030658L (no) | Fremgangsmåte for modulering av multippel ''lineage'' kinaseproteiner og undersökelse av forbindelser som modulerer multippel "lineage"kinaseproteiner | |
| WO2005113526A3 (en) | Metabolites of 4-(3,4-dichloro-phenyl)-2-[2-(4-methyl-piperazin-1-yl)-benzylidene]-thiomorpholin-3-one | |
| NO905511L (no) | Fremgangsmaate for fremstilling av 1-(4-fluorfenyl)-2-(4-((4-metansulfonamido- eller 4-acetamidofenyl)carbonyl)-1-piperidinyl)-etanon. | |
| DE60224805D1 (de) | 1-glycinyl-4-(1-methylpiperidin-4-yl)piperazine un | |
| NO20031698D0 (no) | Krystallformer av 1-(6-klor-5-(trifluormetyl)-2- pyridinyl)piperazin-hydroklorid | |
| SI1436282T1 (en) | Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts | |
| AU2002359274A1 (en) | Synthesis of 4-(piperidyl) (2-pyridyl)methanone-(e)-o-methyloxime and its salts | |
| NO20013498D0 (no) | 1-(Metylpyridin-3-yl)-2-[4-(metylsulfonyl)fenyl]etanon og fremgangsmåte for dets fremstilling |